Organogenesis Holdings, Inc. (ORGO)
1.67
-0.13
(-7.22%)
USD |
NASDAQ |
Aug 24, 16:00
1.67
0.00 (0.00%)
Pre-Market: 09:26
Organogenesis Holdings Debt to Equity Ratio : 0.2324 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2324 |
| March 31, 2026 | 0.1858 |
| December 31, 2025 | 0.1893 |
| September 30, 2025 | 0.1057 |
| June 30, 2025 | 0.113 |
| March 31, 2025 | 0.1158 |
| December 31, 2024 | 0.1124 |
| September 30, 2024 | 0.3819 |
| June 30, 2024 | 0.4212 |
| March 31, 2024 | 0.418 |
| December 31, 2023 | 0.4283 |
| September 30, 2023 | 0.4436 |
| June 30, 2023 | 0.4522 |
| March 31, 2023 | 0.464 |
| December 31, 2022 | 0.466 |
| September 30, 2022 | 0.4983 |
| June 30, 2022 | 0.5037 |
| March 31, 2022 | 0.5353 |
| December 31, 2021 | 0.5482 |
| September 30, 2021 | 0.5925 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.5863 |
| March 31, 2021 | 0.5852 |
| December 31, 2020 | 0.5488 |
| September 30, 2020 | 1.649 |
| June 30, 2020 | 3.04 |
| March 31, 2020 | 2.569 |
| December 31, 2019 | 1.696 |
| September 30, 2019 | 7.402 |
| June 30, 2019 | 3.641 |
| March 31, 2019 | 2.524 |
| December 31, 2018 | 1.404 |
| September 30, 2018 | 0.0023 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.001 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| cbdMD, Inc. | 0.2694 |
| Guardian Pharmacy Services, Inc. | 0.1435 |
| Ironwood Pharmaceuticals, Inc. | -2.452 |
| Verastem, Inc. | 1.687 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 406.45M |
| Total Liabilities (Quarterly) | 118.31M |
| Shareholders Equity (Quarterly) | 288.13M |
| Current Ratio | 3.516 |
| Net Debt Paydown Yield | -1.56% |